These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34853636)
1. New drugs for the treatment of metastatic colorectal cancer. Cherri S; Libertini M; Zaniboni A World J Gastrointest Oncol; 2021 Nov; 13(11):1551-1560. PubMed ID: 34853636 [TBL] [Abstract][Full Text] [Related]
2. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Grothey A; Fakih M; Tabernero J Ann Oncol; 2021 Aug; 32(8):959-967. PubMed ID: 33836264 [TBL] [Abstract][Full Text] [Related]
3. Stage IV Colorectal Cancer Management and Treatment. Hernandez Dominguez O; Yilmaz S; Steele SR J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902858 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond Targeted Therapies in Colon Cancer Today and Tomorrow. Pohl M; Schmiegel W Dig Dis; 2016; 34(5):574-9. PubMed ID: 27332557 [TBL] [Abstract][Full Text] [Related]
5. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer. Jain VK; Hawkes EA; Cunningham D Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675 [TBL] [Abstract][Full Text] [Related]
6. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer. Henry JT; Johnson B Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426 [TBL] [Abstract][Full Text] [Related]
8. Colon Cancer Screening - Is It Time Yet? Bhurgri H; Samiullah S J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276 [TBL] [Abstract][Full Text] [Related]
10. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Wang Q; Shen X; Chen G; Du J Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740594 [TBL] [Abstract][Full Text] [Related]
11. Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion. Fernández-Montes A; Grávalos C; Pericay C; Safont MJ; Benavides M; Élez E; García-Alfonso P; García-Paredes B; Carrato A; Aranda E Clin Colorectal Cancer; 2020 Sep; 19(3):165-177. PubMed ID: 32507561 [TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer: From Genetic Landscape to Targeted Therapy. El Bali M; Bakkach J; Bennani Mechita M J Oncol; 2021; 2021():9918116. PubMed ID: 34326875 [TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies. Saif MW; Kang SP; Chu E Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):11-9. PubMed ID: 17354513 [TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer in Russia. Avksentyeva M Eur J Health Econ; 2010 Jan; 10 Suppl 1():S91-8. PubMed ID: 20012132 [TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications. Effendi-Ys R Acta Med Indones; 2017 Oct; 49(4):351-359. PubMed ID: 29348387 [TBL] [Abstract][Full Text] [Related]
20. Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer. Cimino SK; Eng C J Exp Pharmacol; 2020; 12():475-485. PubMed ID: 33204182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]